BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22647691)

  • 1. Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
    Gautam R; Nishimura Y; Lee WR; Donau O; Buckler-White A; Shingai M; Sadjadpour R; Schmidt SD; LaBranche CC; Keele BF; Montefiori D; Mascola JR; Martin MA
    J Virol; 2012 Aug; 86(16):8516-26. PubMed ID: 22647691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.
    Nishimura Y; Shingai M; Willey R; Sadjadpour R; Lee WR; Brown CR; Brenchley JM; Buckler-White A; Petros R; Eckhaus M; Hoffman V; Igarashi T; Martin MA
    J Virol; 2010 May; 84(9):4769-81. PubMed ID: 20147396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.
    Song RJ; Chenine AL; Rasmussen RA; Ruprecht CR; Mirshahidi S; Grisson RD; Xu W; Whitney JB; Goins LM; Ong H; Li PL; Shai-Kobiler E; Wang T; McCann CM; Zhang H; Wood C; Kankasa C; Secor WE; McClure HM; Strobert E; Else JG; Ruprecht RM
    J Virol; 2006 Sep; 80(17):8729-38. PubMed ID: 16912320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying
    Scinto HB; Gupta S; Thorat S; Mukhtar MM; Griffiths A; Delgado J; Plake E; Vyas HK; Strickland A; Byrareddy SN; Montefiori DC; LaBranche C; Pal R; Treece J; Orndorff S; Ferrari MG; Weiss D; Chenine AL; McLinden R; Michael N; Kim JH; Robb ML; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Ruprecht RM
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
    Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
    Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.
    Ziani W; Bauer A; Lu H; Wang X; Wu X; Bar KJ; Li H; Liu D; Shaw GM; Veazey RS; Xu H
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.
    Ren W; Mumbauer A; Zhuang K; Harbison C; Knight H; Westmoreland S; Gettie A; Blanchard J; Cheng-Mayer C
    Retrovirology; 2013 Jan; 10():9. PubMed ID: 23369442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-GuĂ©rin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication.
    Bose D; Deb Adhikary N; Xiao P; Rogers KA; Ferrell DE; Cheng-Mayer C; Chang TL; Villinger F
    J Virol; 2024 Feb; 98(2):e0165223. PubMed ID: 38299866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
    Endo Y; Igarashi T; Nishimura Y; Buckler C; Buckler-White A; Plishka R; Dimitrov DS; Martin MA
    J Virol; 2000 Aug; 74(15):6935-45. PubMed ID: 10888632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.
    Shingai M; Yoshida T; Martin MA; Strebel K
    J Virol; 2011 Oct; 85(19):9708-15. PubMed ID: 21775449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.
    Mumbauer A; Gettie A; Blanchard J; Cheng-Mayer C
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):496-504. PubMed ID: 23221980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
    Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
    J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus.
    Ho O; Larsen K; Polacino P; Li Y; Anderson D; Song R; Ruprecht RM; Hu SL
    Retrovirology; 2009 Jul; 6():65. PubMed ID: 19602283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxis.
    Siddappa NB; Hemashettar G; Wong YL; Lakhashe S; Rasmussen RA; Watkins JD; Novembre FJ; Villinger F; Else JG; Montefiori DC; Ruprecht RM
    J Med Primatol; 2011 Apr; 40(2):120-8. PubMed ID: 21044092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences.
    Tartaglia LJ; Chang HW; Lee BC; Abbink P; Ng'ang'a D; Boyd M; Lavine CL; Lim SY; Sanisetty S; Whitney JB; Seaman MS; Rolland M; Tovanabutra S; Ananworanich J; Robb ML; Kim JH; Michael NL; Barouch DH
    PLoS Pathog; 2016 Feb; 12(2):e1005431. PubMed ID: 26849216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV).
    Chen Z; Zhao X; Huang Y; Gettie A; Ba L; Blanchard J; Ho DD
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):133-45. PubMed ID: 12045675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
    Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).
    Chen Z; Huang Y; Zhao X; Skulsky E; Lin D; Ip J; Gettie A; Ho DD
    J Virol; 2000 Jul; 74(14):6501-10. PubMed ID: 10864663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.